The US grows marijuana for research. But it’s so awful it’s basically useless.
by
The only marijuana researchers can legally obtain for
studies looks like something you would scrape off the bottom of your
shoe after walking on a grassy field.
This is not an exaggeration. Take a look at this photo,
courtesy of the Multidisciplinary Association for Psychedelic Studies
(MAPS):
This is the marijuana that researchers were sent for a
study looking at whether pot can help treat post-traumatic stress
disorder.
Due to federal prohibition and regulations, all of the
marijuana used for US research is provided by one facility at the
University of Mississippi through the National Institute on Drug Abuse
(NIDA).
But researchers have complained for years that the quality of
marijuana that NIDA supplies is terrible — typically far below what you
can get from state-legal medical or recreational marijuana markets or
even the black market.
The photo above exemplifies this. The marijuana looks
like it’s made up more of leaves and stems than the actual bud you’re
supposed to smoke. As anyone who’s ever smoked pot can tell you, you’re
typically supposed to throw out the leaves and stems — meaning what you
see in the photo is basically garbage to the typical user. Usable pot is
supposed to look chunkier and laced with crystals that are high in THC
(which is what gets you high).
Here’s an example of higher-quality pot, taken before the stems are fully removed:
But as Christopher Ingraham and Tauhid Chappell reported at the Washington Post,
the problem is not solely aesthetic. The NIDA-provided marijuana was
supposed to have 13 percent THC content, but the MAPS researchers’ own
testing found it was closer to 8 percent. (In comparison, state-legal
commercial marijuana is typically at 19 percent but can go up to 30
percent or more.) There were also high mold and yeast levels — far
beyond what you’d see in state-legal medical marijuana — but ultimately
not the kind of mold or yeast that’s harmful to humans.
Yet thanks to the federally enforced monopoly on pot for research, this is the pot that researchers have to work with.
That makes the research questionable. Will it understate
pot’s medical benefits, since this pot provided by the government is far
weaker than what patients would actually use in the real world?
Given
that the government can’t get THC levels right, how can researchers be
sure that federally provided marijuana won’t fail in other respects,
such as the levels of other crucial chemicals like CBD?
And since researchers know that the quality of pot they’ll get from the
government is bad, how many give up without even trying?
These kinds of hurdles are why, even as marijuana has
been with humans in some form of another for thousands of years, we
still have little idea of what marijuana’s benefits and harms truly are.
Our lack of knowledge then helps perpetuate prohibition.
One reason that pot remains a highly restricted, fully prohibited
substance at the federal level is because there are no large-scale
clinical trials proving its medical value and safety. But a major reason
for the lack of large-scale clinical trials is that federal prohibition
limits researchers’ access to good marijuana — by, for example, letting
NIDA claim a monopoly on what kind of pot researchers can use. (If pot
was legal, researchers could just obtain the drug from a retailer — much
like, say, a researcher looking into alcohol or tobacco could.) This
is, in other words, a Catch-22.
It’s possible, the Post reported, that this is a
particularly bad strain of NIDA’s marijuana. When I asked about this,
the agency told me, “The marijuana provided by the University of
Mississippi farm supported by NIDA is dried and frozen before being
shipped and hence it will look different from the more commonly familiar
dried plant sold in dispensaries. However, this does not impact the
chemical constituents found within the plant, including THC levels.”
NIDA did tell the Post that “there has been some emerging
interest from the research community for a wider variety of marijuana
and marijuana products. … NIDA does plan on growing some additional
marijuana this year and harvest some high THC material that will likely
be above 13 percent THC.”
No comments:
Post a Comment